California grants $7.4 million to advance gene-edited stem cell therapy for Friedreich’ s ataxia
The California Institute for Regenerative Medicine (CIRM) has awarded $7.4 million to support a University of California San Diego team developing a first-of-its-kind stem cell-based gene therapy for Friedreich’s ataxia,…
Stem cell engineering breakthrough paves way for next-generation living drugs
For the first time, researchers at the University of British Columbia have demonstrated how to reliably produce an important type of human immune cell—known as helper T cells—from stem cells…
Long-Term Study Suggests Walking Is Key to Managing Cancer-Related Fatigue #IG26 #ASCO
A new study found that regular physical activity, particularly walking, can significantly reduce cancer-related fatigue and improve quality of life in people with colorectal cancer, especially in the post-treatment setting.…
Antibody-drug conjugates emerge as potent anti-tumor agents for gynecological cancers
Gynecological cancers, primarily cervical, ovarian, and uterine cancer, continue to be a significant threat to women’s health worldwide. While surgery and chemotherapy are the current standard treatment, patients often face…
World marks cervical cancer elimination day as countries accelerate action
Today marks the first World Cervical Cancer Elimination Day – mandated by the World Health Assembly – a historic milestone in global efforts to end a preventable cancer. This day…
Evolving antibiotic resistance under pressure
The bacteria Acinetobacter baumannii (A. baumannii) is a haunting presence in many hospitals in the United States, where more than one in 100 patients are treated for A. baumannii infections.…
AI analysis of world’s largest heart attack datasets opens way to new treatment strategies
A landmark international study led by the University of Zurich has shown that artificial intelligence can assess patient risk for the most common type of heart attack more accurately than…
11 million lives lost each year: urgent action needed on neurological care
The World Health Organization (WHO) today warns that less than one in three countries around the world has a national policy to address the growing burden of neurological disorders, responsible…
FDA approves PharmaMar’s Zepzelca® (lurbinectedin) and Atezolizumab (Tecentriq®) Combination as First-line Maintenance Therapy for Extensive-stage Small Cell Lung Cancer
harmaMar (MSE:PHM) has announced that the U.S Food and Drug Administration (FDA) has granted approval for Zepzelca® (lurbinectedin) in combination with atezolizumab (Tecentriq®) as a maintenance treatment for adults with…
Genetic testing of IVF embryos helps women over 35 conceive faster
Genetic testing of IVF-created embryos could help more women over 35 have a baby in less time, a clinical trial by researchers from King’s College London, King’s College Hospital, and…